封面
市場調查報告書
商品編碼
1411616

避孕藥市場:依產品、年齡層、給藥途徑、分佈 - 全球預測 2024-2030

Contraceptive Pills Market by Product (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Route of Administration, Distribution - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年避孕藥具市場規模為195.3億美元,預計2024年將達207.6億美元,2030年將達302.7億美元,複合年成長率為6.46%。

全球避孕藥市場

主要市場統計
基準年[2023] 195.3億美元
預測年份 [2024] 207.6億美元
預測年份 [2030] 302.7億美元
複合年成長率(%) 6.46%
避孕藥市場-IMG1

避孕藥是含有合成荷爾蒙的口服藥物,旨在調節女性的月經週期並防止意外懷孕。這些藥物的主要作用是抑制排卵、改變子宮頸黏液以限制精子的通過,以及改變子宮內膜以最大限度地減少受精卵的著床。不同年齡層和文化對計劃生育方法的認知不斷提高,對安全有效避孕藥具的需求也隨之增加。然而,由於市場上有替代避孕方法和不合格產品,消費者取得避孕藥具的機會受到限制。然而,開拓具有更高功效和更少副作用的新配方預計將為避孕市場提供潛在機會。

區域洞察

在美洲,由於廣泛的宣傳宣傳活動、政府支持以及製造商在新避孕藥配方方面的技術進步,避孕藥市場正在擴大。根據美國國家醫學圖書館 (NLM) 的數據,目前美國15 歲至 44 歲的女性中約有 25% 選擇避孕藥作為避孕方法。在歐洲地區,促進計劃生育教育和負擔能力的公共衛生計劃使避孕藥具的使用變得流行。亞太地區面臨中國和印度等人口稠密的經濟體,創造了對負擔得起的避孕藥具的需求並呈現出市場成長前景。此外,許多新興和開發中國家正在透過推出計劃生育教育和宣傳計劃為市場創造機會。

FPNV定位矩陣

FPNV定位矩陣對於評估避孕市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市場佔有率分析

市場佔有率分析是一種綜合工具,可以對避孕市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略,從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解:

1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。

3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題:

1-避孕藥市場的市場規模和預測是多少?

2-避孕藥市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?

3-避孕市場的技術趨勢和法律規範是什麼?

4-避孕藥市場主要供應商的市場佔有率是多少?

5-進入避孕藥具市場的適當型態或策略手段是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加避孕藥具的使用,防止意外懷孕
      • 提高性行為感染傳染病 (STD) 的盛行率和認知
      • 政府支持促進避孕藥具的使用
    • 抑制因素
      • 避孕藥對健康的不良影響
    • 機會
      • 避孕藥配方和包裝的持續進步
      • 線上管道提供避孕藥具
    • 任務
      • 有關錠劑使用和產品行銷問題的安全和社會問題
  • 市場區隔分析
    • 產品:計劃生育聯合藥物的大量採用
    • 年齡層:15-24歲年齡層避孕藥具使用率較高。
    • 經銷:避孕藥具線上通路的演變
    • 管理途徑:依易用性區分使用者對口服避孕藥的偏好
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 避孕藥市場:依產品

  • 組合藥丸
  • 延續/延長藥丸
  • 黃體酮錠劑

第7章 避孕藥市場:依年齡層別

  • 15-24
  • 25-34
  • 35-44
  • 45歲以上

第8章 避孕藥市場:給藥給藥途徑

  • 口服
  • 視覺的

第9章 避孕藥市場分佈

  • 離線
  • 線上的

第10章美洲避孕藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太避孕市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲避孕市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析:主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強

第14章競爭產品組合

  • 主要公司簡介
    • AbbVie Inc.
    • Afaxys Pharma, LLC
    • Amneal Pharmaceuticals, Inc.
    • Apotex Inc.
    • Aurobindo Pharma Limited
    • Bayer AG
    • Bionpharma Inc.
    • Cipla Limited
    • Combe Incorporated
    • Gedeon Richter PLC
    • Glenmark Pharmaceuticals Limited
    • Johnson & Johnson Services, Inc.
    • Julie Product Inc.
    • Lupin Limited
    • Mankind Pharma Ltd.
    • Mayne Pharma Group Limited
    • Merck & Co., Inc.
    • Northstar Rx LLC
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Sun Pharmaceutical Industries Limited
    • Syzygy Healthcare Solutions, LLC
    • Teva Pharmaceuticals
    • Viatris Inc.
    • Xiromed, LLC
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-A579C4315A26

[182 Pages Report] The Contraceptive Pills Market size was estimated at USD 19.53 billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 6.46% to reach USD 30.27 billion by 2030.

Global Contraceptive Pills Market

KEY MARKET STATISTICS
Base Year [2023] USD 19.53 billion
Estimated Year [2024] USD 20.76 billion
Forecast Year [2030] USD 30.27 billion
CAGR (%) 6.46%
Contraceptive Pills Market - IMG1

Contraceptive pills are oral medications that contain synthetic hormones designed to regulate a woman's menstrual cycle and prevent unintended pregnancy. These pharmaceutical products primarily function by inhibiting ovulation, altering the cervical mucus to restrict sperm passage, and modifying the endometrial lining to minimize implantation of a fertilized egg. The growing awareness about family planning methods among different age groups and cultures has increase the demand for safe and effective contraceptives. However, the presence of alternative contraceptive methods or substandard products in the market limits consumers' utilization of contraceptive pills. Nevertheless, developing new formulations that offer improved efficacy and fewer side effects is expected to create potential opportunities for the contraceptive pills market.

Regional Insights

In the Americas region, the contraceptive pills market is growing owing to widespread awareness campaigns, government support, and technological advancements from manufacturers for new contraceptive pill composition. According to the National Library of Medicine (NLM), Approximately 25% of women in the U.S. aged 15-44 currently use contraception pills as their method of choice. In the European region, public health programs promoting family planning education and affordable prices have gained popularity for the use of contraceptive pills. The Asia Pacific region showcases growth prospects for the market in the face of larger population economies such as China & India, creating demand for affordable contraceptive pills. Further, many emerging & developing countries create an opportunistic landscape for the market through the adoption of family planning education & awareness programs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Contraceptive Pills Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contraceptive Pills Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Teva Pharmaceuticals, Viatris Inc., and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Combination Pill
    • Continuous/Extended Pill
    • Progesterone Pill
  • Age Group
    • 15-24
    • 25-34
    • 35-44
    • 45 and Above
  • Route of Administration
    • Oral
    • Viginal
  • Distribution
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Contraceptive Pills Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contraceptive Pills Market?

3. What are the technology trends and regulatory frameworks in the Contraceptive Pills Market?

4. What is the market share of the leading vendors in the Contraceptive Pills Market?

5. Which modes and strategic moves are suitable for entering the Contraceptive Pills Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Contraceptive Pills Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of contraceptive pills to prevent unintended pregnancies
      • 5.1.1.2. Growing prevalence and awareness toward sexually transmitted diseases (STDs)
      • 5.1.1.3. Supportive government initiatives to encourage use of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of contraceptive pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in contraceptive pill formulations and packaging
      • 5.1.3.2. Availability of contraceptive pills on online channels
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and social concerns regarding pill usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant adoption of combination pills for family planning
    • 5.2.2. Age Group: High usage of contraceptive pills in the age group 15 to 24
    • 5.2.3. Distribution: Evolving online distribution channels for contraceptive pills
    • 5.2.4. Route of Administration: User preferences for oral contraceptive pills owing to ease of use
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Contraceptive Pills Market, by Product

  • 6.1. Introduction
  • 6.2. Combination Pill
  • 6.3. Continuous/Extended Pill
  • 6.4. Progesterone Pill

7. Contraceptive Pills Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24
  • 7.3. 25-34
  • 7.4. 35-44
  • 7.5. 45 and Above

8. Contraceptive Pills Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Viginal

9. Contraceptive Pills Market, by Distribution

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas Contraceptive Pills Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Contraceptive Pills Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Contraceptive Pills Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Richter and Mithra sign supply agreement for production of API for combined oral contraceptive Estelle and Donesta
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. FDA approves first nonprescription daily oral contraceptive
      • 13.3.2.2. Gedeon Richter announces availability of oral contraception Drovelis

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AbbVie Inc.
    • 14.1.2. Afaxys Pharma, LLC
    • 14.1.3. Amneal Pharmaceuticals, Inc.
    • 14.1.4. Apotex Inc.
    • 14.1.5. Aurobindo Pharma Limited
    • 14.1.6. Bayer AG
    • 14.1.7. Bionpharma Inc.
    • 14.1.8. Cipla Limited
    • 14.1.9. Combe Incorporated
    • 14.1.10. Gedeon Richter PLC
    • 14.1.11. Glenmark Pharmaceuticals Limited
    • 14.1.12. Johnson & Johnson Services, Inc.
    • 14.1.13. Julie Product Inc.
    • 14.1.14. Lupin Limited
    • 14.1.15. Mankind Pharma Ltd.
    • 14.1.16. Mayne Pharma Group Limited
    • 14.1.17. Merck & Co., Inc.
    • 14.1.18. Northstar Rx LLC
    • 14.1.19. Perrigo Company plc
    • 14.1.20. Pfizer Inc.
    • 14.1.21. Piramal Enterprises Ltd.
    • 14.1.22. Sun Pharmaceutical Industries Limited
    • 14.1.23. Syzygy Healthcare Solutions, LLC
    • 14.1.24. Teva Pharmaceuticals
    • 14.1.25. Viatris Inc.
    • 14.1.26. Xiromed, LLC
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTRACEPTIVE PILLS MARKET DYNAMICS
  • FIGURE 7. CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 10. CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 14. CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CONTRACEPTIVE PILLS MARKET SIZE, BY CONTINUOUS/EXTENDED PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 10. CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. CONTRACEPTIVE PILLS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CONTRACEPTIVE PILLS MARKET SIZE, BY VIGINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 18. CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. CONTRACEPTIVE PILLS MARKET LICENSE & PRICING